Nektar holder plans $603K sale of 10,000 shares

Nektar Therapeutics insider filing (Form 144) reports proposed sales.

Rhea-AI Filing Summary

Nektar Therapeutics insider filing (Form 144) reports proposed sales. The notice lists two recent dispositions: 444 shares sold on 05/19/2026 for $29,084.53 and 10,000 shares sold on 06/16/2026 for $603,137.31. The filing also lists multiple Restricted Stock Vesting entries with specific vested share counts and dates.

Insights

Securities Compliance Analyst

Form 144 lists proposed dispositions by an insider, with two recent sales documented.

The notice records a 444-share sale on 05/19/2026 for $29,084.53 and a 10,000-share sale on 06/16/2026 for $603,137.31. These are reported as sales on the Form 144 excerpt.

Details such as the seller's title, any Rule 10b5-1 plan, and proceeds recipient are not stated in the excerpt; subsequent filings or broker confirmations would provide that context.

Key Figures

Sale on 05/19/2026: 444 shares Proceeds on 05/19/2026: $29,084.53 Sale on 06/16/2026: 10,000 shares +3 more

6 metrics

Sale on 05/19/2026 444 shares Disposal reported on Form 144

Proceeds on 05/19/2026 $29,084.53 Amount listed alongside 444-share sale

Sale on 06/16/2026 10,000 shares Disposal reported on Form 144

Proceeds on 06/16/2026 $603,137.31 Amount listed alongside 10,000-share sale

Vested Restricted Stock (example) 2,494 shares Restricted Stock Vesting on 05/15/2022

Brokerage reference 10,000 Fidelity Brokerage Services LLC line item in excerpt

Key Terms

Form 144, Restricted Stock Vesting, Proceeds

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months | Howard Robin ..."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 05/15/2022 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Proceeds financial

"444 | 29084.53 ... 10000 | 603137.31"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the NKTR Form 144 disclose about insider sales?

The filing disclosed two sales: 444 shares sold on 05/19/2026 for $29,084.53 and 10,000 shares sold on 06/16/2026 for $603,137.31. The notice records these dispositions as reported on Form 144.

Who is listed as the seller in the NKTR Form 144 excerpt?

The excerpt names Howard Robin with an address in South San Francisco as the person associated with the two reported sales on 05/19/2026 and 06/16/2026. The filing shows his transactions but not role or title.

Does the Form 144 excerpt show vested restricted stock for NKTR?

Yes. The filing lists multiple Restricted Stock Vesting entries with dates and vested share counts: 2,494 on 05/15/2022, 2,085 on 11/15/2022, 2,265 on 02/15/2023, 1,872 on 05/15/2024, and 1,284 on 08/15/2024.

What cash amounts are reported for the two sales in the NKTR Form 144?

The two reported sales show proceeds of $29,084.53 for the 444-share sale and $603,137.31 for the 10,000-share sale, each listed next to the corresponding transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/17/2026 - 11:05 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001206869
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NEKTAR THERAPEUTICS
SEC File Number	000-24006
Address of Issuer	455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CALIFORNIA 94158
Phone	4154825300
Name of Person for Whose Account the Securities are To Be Sold	ROBIN HOWARD W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	602700.00	33786032	06/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2022	Restricted Stock Vesting	Issuer			2494	05/15/2022	Compensation
Common	11/15/2022	Restricted Stock Vesting	Issuer			2085	11/15/2022	Compensation
Common	02/15/2023	Restricted Stock Vesting	Issuer			2265	02/15/2023	Compensation
Common	05/15/2024	Restricted Stock Vesting	Issuer			1872	05/15/2024	Compensation
Common	08/15/2024	Restricted Stock Vesting	Issuer			1284	08/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Howard Robin 455 Mission Bay Boulevard South San Francisco CA 94158	Common	05/19/2026	444	29084.53
Howard Robin 455 Mission Bay Boulevard South San Francisco CA 94158	Common	06/16/2026	10000	603137.31

144: Remarks and Signature

Remarks
Date of Notice	06/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Howard Robin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)